Our results showed that while ATM kinase inhibition reduced cyst growth in vitro, the reduction of ATM by genetic ablation did not alter the progression of cystic kidney disease in a well-established murine genetic ortholog of ADPKD. This evidence concerns the gene ATM and autosomal dominant polycystic kidney disease.